Original Research
Published on 14 Jul 2020
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.01095
- 6,529 views
- 10 citations
